Drug Type Monoclonal antibody |
Synonyms BC3425 |
Target |
Mechanism 4-1BB modulators(Tumor necrosis factor receptor superfamily member 9 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 1 | CN | 30 Nov 2022 |